Form4insider filings, from the source

Company · CIK 0001386570 · SIC 2833 — Medicinal Chemicals & Botanical Products · Nasdaq

Niagen Bioscience, Inc. · NAGE

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jun 30, 2026 AForm 4 →Jul 8, 5:18 pm EDTCarlos Luis LopezSVP, General Counsel2,314$2.71$6,2714,565— late
Jun 30, 2026 AForm 4 →Jul 8, 5:17 pm EDTOzan PamirChief Financial Officer4,255$2.71$11,53111,627— late
Jun 30, 2026 AForm 4 →Jul 8, 5:16 pm EDTRobert N FriedChief Executive Officer, Director1,106$2.71$2,9971,060,087— late

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jun 24, 2026 AForm 4 →Jun 26, 6:03 pm EDTWing Tak Wendy YUDirector31,746——31,746—
Jun 24, 2026 AForm 4 →Jun 26, 6:02 pm EDTWang Yu Gary NgDirector31,746——31,746—
Jun 24, 2026 AForm 4 →Jun 26, 6:01 pm EDTAnn CohenDirector31,746——31,746—
Jun 24, 2026 AForm 4 →Jun 26, 5:57 pm EDTKristin PatrickDirector31,746——31,746—
Jun 24, 2026 AForm 4 →Jun 26, 5:56 pm EDTHamed ShahbaziDirector31,746——31,746—
Jun 24, 2026 AForm 4 →Jun 26, 5:55 pm EDTSteven D RubinDirector31,746——31,746—
Jun 24, 2026 AForm 4 →Jun 26, 5:54 pm EDTFrank L Jaksch Jr.Director31,746——31,746—